JP2001524931A5 - - Google Patents

Download PDF

Info

Publication number
JP2001524931A5
JP2001524931A5 JP1998508118A JP50811898A JP2001524931A5 JP 2001524931 A5 JP2001524931 A5 JP 2001524931A5 JP 1998508118 A JP1998508118 A JP 1998508118A JP 50811898 A JP50811898 A JP 50811898A JP 2001524931 A5 JP2001524931 A5 JP 2001524931A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP1998508118A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001524931A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1997/013622 external-priority patent/WO1998005333A1/en
Publication of JP2001524931A publication Critical patent/JP2001524931A/ja
Publication of JP2001524931A5 publication Critical patent/JP2001524931A5/ja
Pending legal-status Critical Current

Links

JP50811898A 1996-08-05 1997-08-05 プロテアーゼおよびキナーゼのインヒビターとしてならびに転写因子のインヒビターとしてのβシート模倣物の使用 Pending JP2001524931A (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US69242096A 1996-08-05 1996-08-05
US08/692,420 1996-08-05
US72507396A 1996-10-02 1996-10-02
US08/725,073 1996-10-02
US79791597A 1997-02-10 1997-02-10
US08/797,915 1997-02-10
US4706797P 1997-05-19 1997-05-19
US60/047,067 1997-05-19
PCT/US1997/013622 WO1998005333A1 (en) 1996-08-05 1997-08-05 Use of beta-sheet mimetics as protease and kinase inhibitors and as inhibitors of transcription factors

Publications (2)

Publication Number Publication Date
JP2001524931A JP2001524931A (ja) 2001-12-04
JP2001524931A5 true JP2001524931A5 (https=) 2005-04-07

Family

ID=27489127

Family Applications (1)

Application Number Title Priority Date Filing Date
JP50811898A Pending JP2001524931A (ja) 1996-08-05 1997-08-05 プロテアーゼおよびキナーゼのインヒビターとしてならびに転写因子のインヒビターとしてのβシート模倣物の使用

Country Status (11)

Country Link
EP (1) EP0915700B1 (https=)
JP (1) JP2001524931A (https=)
KR (1) KR20000029838A (https=)
AT (1) ATE320811T1 (https=)
AU (1) AU732174B2 (https=)
CA (1) CA2262900A1 (https=)
DE (1) DE69735545T2 (https=)
ES (1) ES2262184T3 (https=)
NO (1) NO990522L (https=)
NZ (1) NZ334227A (https=)
WO (1) WO1998005333A1 (https=)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6184223B1 (en) 1995-10-27 2001-02-06 Molecumetics Ltd. Reverse-turn mimetics and methods relating thereto
DE69810513T2 (de) * 1998-02-12 2004-03-18 Molecumetics, Ltd., Bellevue Mimetika von beta-faltblatt und verfahren zur verwendung davon
US6323219B1 (en) 1998-04-02 2001-11-27 Ortho-Mcneil Pharmaceutical, Inc. Methods for treating immunomediated inflammatory disorders
US8106094B2 (en) 1998-07-06 2012-01-31 Johnson & Johnson Consumer Companies, Inc. Compositions and methods for treating skin conditions
US8093293B2 (en) 1998-07-06 2012-01-10 Johnson & Johnson Consumer Companies, Inc. Methods for treating skin conditions
WO2000038683A1 (en) 1998-12-23 2000-07-06 Du Pont Pharmaceuticals Company THROMBIN OR FACTOR Xa INHIBITORS
CZ20012722A3 (cs) 1999-01-27 2002-08-14 Ortho-Mcneil Pharmaceutical, Inc. Peptidylové heterocyklické ketony pouľitelné jako inhibitory typtasy
US7309688B2 (en) 2000-10-27 2007-12-18 Johnson & Johnson Consumer Companies Topical anti-cancer compositions and methods of use thereof
US7253169B2 (en) 1999-11-12 2007-08-07 Gliamed, Inc. Aza compounds, pharmaceutical compositions and methods of use
US6417189B1 (en) * 1999-11-12 2002-07-09 Gpi Nil Holdings, Inc. AZA compounds, pharmaceutical compositions and methods of use
EP1261611A2 (en) * 2000-02-29 2002-12-04 Bristol-Myers Squibb Pharma Company Inhibitors of hepatitis c virus ns3 protease
US8431550B2 (en) 2000-10-27 2013-04-30 Johnson & Johnson Consumer Companies, Inc. Topical anti-cancer compositions and methods of use thereof
DE10100053A1 (de) * 2001-01-02 2002-08-22 Keyneurotek Ag I G Verwendung von Enzyminhibitoren der Dipeptidylpeptidase IV sowie der Aminopeptidase N und pharmazeutischen Zubereitungen daraus zur Prävention und/oder Therapie Ischämie-bedingter akuter und chronischer neurodegenerativer Prozesse und Erkrankungen
US7192615B2 (en) 2001-02-28 2007-03-20 J&J Consumer Companies, Inc. Compositions containing legume products
US8080657B2 (en) 2001-10-12 2011-12-20 Choongwae Pharma Corporation Compounds of reverse turn mimetics and the use thereof
US7671054B1 (en) 2001-10-12 2010-03-02 Choongwae Pharma Corporation Reverse-turn mimetics and method relating thereto
US7576084B2 (en) 2001-10-12 2009-08-18 Choongwae Pharma Corporation Reverse-turn mimetics and method relating thereto
US7232822B2 (en) 2001-10-12 2007-06-19 Choongwae Pharma Corporation Reverse-turn mimetics and method relating thereto
US7566711B2 (en) 2001-10-12 2009-07-28 Choongwae Pharma Corporation Reverse-turn mimetics and method relating thereto
WO2003055856A2 (en) 2001-10-17 2003-07-10 Bristol-Myers Squibb Company BICYCLIC LACTAM DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES AND/OR TNF-α CONVERTING ENZYME (TACE)
TWI286476B (en) * 2001-12-12 2007-09-11 Tibotec Pharm Ltd Combination of cytochrome P450 dependent protease inhibitors
CA2502644A1 (en) 2002-10-17 2004-04-29 Myriad Genetics, Inc. Reverse-turn mimetics and composition and methods relating thereto
CN102906566A (zh) * 2010-02-03 2013-01-30 株式会社棱镜生物实验室 与天然变性蛋白质结合的化合物及其筛选方法
MX378266B (es) 2014-10-06 2025-03-10 Lighthouse Pharmaceuticals Inc Inhibidores de gingipaina de lisina.
CN108602787A (zh) 2015-11-09 2018-09-28 库特克希米公司 精氨酸牙龈卟啉菌蛋白酶的抑制剂
CN109983012B (zh) 2016-09-16 2023-12-01 莱特豪斯制药公司 赖氨酸牙龈蛋白酶的酮抑制剂

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1600880A (en) * 1978-05-23 1981-10-21 Lilly Industries Ltd Pharmaceutical compositions comprising hydantoin derivatives
IL60617A0 (en) * 1979-07-23 1980-09-16 Sparamedica Ag Triazolopyridazine derivative,their preparation and pharmaceutical compositions containing them
US4594431A (en) * 1983-08-01 1986-06-10 Eli Lilly Company Octahydroindolizinepropanoic acids and related compounds as enzyme inhibitors
JPH0676373B2 (ja) * 1985-12-27 1994-09-28 エーザイ株式会社 グアニジノ安息香酸エステル誘導体
AU653024B2 (en) * 1991-05-30 1994-09-15 Novartis Ag Substituted diaminophthalimides and analogues
US5463063A (en) * 1993-07-02 1995-10-31 Celgene Corporation Ring closure of N-phthaloylglutamines
US5716929A (en) * 1994-06-17 1998-02-10 Vertex Pharmaceuticals, Inc. Inhibitors of interleukin-1β converting enzyme
AP9701004A0 (en) * 1994-12-22 1997-07-31 Iaf Biochem Int Low molecular weight bicyclic thrombin inhibitors.
HU226558B1 (en) * 1994-12-30 2009-03-30 Celgene Corp Immunotherapeutic imides/amides and their use for reducing levels of tnfalpha
JPH10508034A (ja) * 1995-03-24 1998-08-04 モレキュメティックス リミテッド βシート模倣物および生物学的に活性なペプチドまたはタンパク質のインヒビターとしてのその使用
WO1996030396A1 (en) * 1995-03-24 1996-10-03 Molecumetics Ltd. β-SHEET MIMETICS AND USE THEREOF AS PROTEASE INHIBITORS
IT1277405B1 (it) * 1995-08-01 1997-11-10 Menarini Farma Ind Derivati di lattami biciclici come inibitori della trombina

Similar Documents

Publication Publication Date Title
JP2000502280A5 (https=)
JP2000501771A5 (https=)
JP2000501599A5 (https=)
JP2001519767A5 (https=)
JP2000500076A5 (https=)
JP2001512497A5 (https=)
JP2000500055A5 (https=)
JP2000500026A5 (https=)
JP2000502472A5 (https=)
JP2000501825A5 (https=)
JP2001507166A5 (https=)
JP2000502425A5 (https=)
JP2000502485A5 (https=)
JP2000502568A5 (https=)
JP2000501774A5 (https=)
JP2000500912A5 (https=)
JP2000502570A5 (https=)
JP2000501876A5 (https=)
JP2000501744A5 (https=)
JP2000502316A5 (https=)
JP2000502714A5 (https=)
JP2000511230A5 (https=)
JP2000501569A5 (https=)
JP2000500184A5 (https=)
JP2001524931A5 (https=)